BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38235069)

  • 1. Development and Validation of a Nomogram to Predict the Recurrence of HCC Patients Undergoing CECT After Ablation.
    Qiao W; Fan Z; Wang Q; Jin R; Hu C
    J Hepatocell Carcinoma; 2024; 11():65-79. PubMed ID: 38235069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of a machine learning-based nomogram to predict the prognosis of HBV associated hepatocellular carcinoma patients with high levels of hepatitis B surface antigen in primary local treatment: a multicenter study.
    Xiong Y; Qiao W; Wang Q; Li K; Jin R; Zhang Y
    Front Immunol; 2024; 15():1357496. PubMed ID: 38601167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating Inflammatory Markers and Clinical Indicators into a Predictive Model of Single Small Hepatocellular Carcinoma Recurrence After Primary Locoregional Treatments.
    Qiao W; Xiong Y; Li K; Jin R; Zhang Y
    J Hepatocell Carcinoma; 2024; 11():1113-1125. PubMed ID: 38887683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments.
    Sun Y; Xiong Y; Wang Q; Qiao W; Zhang H; Zhang Y
    Front Oncol; 2023; 13():1206345. PubMed ID: 37700838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation.
    Qiao W; Li J; Wang Q; Jin R; Zhang H
    J Hepatocell Carcinoma; 2024; 11():271-284. PubMed ID: 38333222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
    Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
    Front Oncol; 2021; 11():742630. PubMed ID: 34745962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram built based on machine learning to predict recurrence in early-stage hepatocellular carcinoma patients treated with ablation.
    Zhang H; Sheng S; Qiao W; Sun Y; Jin R
    Front Oncol; 2024; 14():1395329. PubMed ID: 38800405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
    Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
    Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
    [No Abstract]   [Full Text] [Related]  

  • 9. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
    Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
    Front Oncol; 2022; 12():946531. PubMed ID: 35936698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nomogram prognostic model for early hepatocellular carcinoma with diabetes mellitus after primary liver resection based on the admission characteristics.
    Zhang M; Wang Q; Zhang G; Li G; Jin R; Xing H
    Front Pharmacol; 2024; 15():1360478. PubMed ID: 38434702
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel nomogram to predict the recurrence of hepatocellular carcinoma after liver transplantation using extended selection criteria.
    Gu YG; Xue HY; Ma ES; Jiang SR; Li JH; Wang ZX
    Hepatobiliary Pancreat Dis Int; 2024 Jun; ():. PubMed ID: 38890106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung immune prognostic index‑based nomogram for recurrence of hepatocellular carcinoma after postoperative adjuvant TACE.
    Liang Y; Yang R; Shang J; Zhong D; Yang Q; Su Y; Shi Y; Huang X
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16461-16471. PubMed ID: 37707573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram.
    Zhao JW; Shu X; Chen XX; Liu JX; Liu MQ; Ye J; Jiang HJ; Wang GS
    Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):543-550. PubMed ID: 35705443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. External validation and improvement of the scoring system for predicting the prognosis in hepatocellular carcinoma after interventional therapy.
    Qiao W; Wang Q; Mei T; Wang Q; Wang W; Zhang Y
    Front Surg; 2023; 10():1045213. PubMed ID: 36936655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic nomogram for hepatocellular carcinoma after thermal ablation.
    Tao Q; Zeng Q; Liu W; Liu J; Jiang L; Tu X; Li K; Zhao P; Tang X; Liu Z; Wang L; Xu Q; Zheng Y
    Am J Cancer Res; 2021; 11(10):5126-5140. PubMed ID: 34765316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Low HBV-DNA Viral Load on Recurrence in Hepatocellular Carcinoma Patients Who Underwent Primary Locoregional Treatment and the Development of a Nomogram Prediction Model.
    Xiong Y; Wang Z; Liu J; Li K; Zhang Y
    Microorganisms; 2024 May; 12(5):. PubMed ID: 38792805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-Enhanced CT Imaging Features Combined with Clinical Factors to Predict the Efficacy and Prognosis for Transarterial Chemoembolization of Hepatocellular Carcinoma.
    Sun Z; Shi Z; Xin Y; Zhao S; Jiang H; Li J; Li J; Jiang H
    Acad Radiol; 2023 Sep; 30 Suppl 1():S81-S91. PubMed ID: 36803649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
    Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
    J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
    Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
    JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.